Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IVIG in Preterm Infants With Encephalopathy of Prematurity
NCT02822027Unknown
- Start
- Jun 2016
- Primary completion
- Dec 2024
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Trial of immune globulin in encephalopathy (2 arms). Primary endpoints: Structural changes of brain injury at 100 days and Functional changes of brain injury at 100 days. Status: unknown.
02
Drugs
immune globulin
03
Conditions
encephalopathy
Beyond the preview
Go deeper on NCT02822027.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02822027.